These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
41 related items for PubMed ID: 6374718
21. The dexamethasone suppression test and cerebral blood flow in primary major depression. Charles G, Uytdenhoef P, Portelange P, Wilmotte J, Mendlewicz J, Jacquy J. Biol Psychiatry; 1983 Nov; 18(11):1336-8. PubMed ID: 6652166 [No Abstract] [Full Text] [Related]
25. The application of serial neuroendocrine challenge studies in the management of depressive disorder. Targum SD. Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062 [Abstract] [Full Text] [Related]
26. Dexamethasone suppression test: use of two different dexamethasone doses. Hwang S, Zander J, Garvey M. J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924 [Abstract] [Full Text] [Related]
30. Normalization of dexamethasone test associated with social support system improvement. Schwartz LS. Psychiatr J Univ Ott; 1984 Mar; 9(1):45-6. PubMed ID: 6374718 [No Abstract] [Full Text] [Related]
31. The dexamethasone suppression test during recurrent major depressive episodes. Yerevanian BI, Privitera MR, Milanese E, Sagi EA, Russotto JC. Biol Psychiatry; 1984 Mar; 19(3):407-12. PubMed ID: 6722230 [No Abstract] [Full Text] [Related]
32. [Dexamethasone suppression test in depressions: an indicator of endogenicity?]. Ruef C, Modestin J. Schweiz Rundsch Med Prax; 1987 Jun 23; 76(26):747-51. PubMed ID: 3616333 [No Abstract] [Full Text] [Related]
33. Depressive disorders in children. Validation of clinical syndromes. Cantwell DP. Psychiatr Clin North Am; 1985 Dec 23; 8(4):779-92. PubMed ID: 4080623 [Abstract] [Full Text] [Related]
34. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse. Targum SD. Biol Psychiatry; 1984 Mar 23; 19(3):305-18. PubMed ID: 6426529 [Abstract] [Full Text] [Related]
35. Normalization of dexamethasone test associated with social support system improvement. Schwartz LS. Psychiatr J Univ Ott; 1984 Mar 23; 9(1):45-6. PubMed ID: 6374718 [No Abstract] [Full Text] [Related]
36. The dexamethasone suppression test during recurrent major depressive episodes. Yerevanian BI, Privitera MR, Milanese E, Sagi EA, Russotto JC. Biol Psychiatry; 1984 Mar 23; 19(3):407-12. PubMed ID: 6722230 [No Abstract] [Full Text] [Related]
37. [Dexamethasone suppression test in depressions: an indicator of endogenicity?]. Ruef C, Modestin J. Schweiz Rundsch Med Prax; 1987 Jun 23; 76(26):747-51. PubMed ID: 3616333 [No Abstract] [Full Text] [Related]
38. Depressive disorders in children. Validation of clinical syndromes. Cantwell DP. Psychiatr Clin North Am; 1985 Dec 23; 8(4):779-92. PubMed ID: 4080623 [Abstract] [Full Text] [Related]
39. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse. Targum SD. Biol Psychiatry; 1984 Mar 23; 19(3):305-18. PubMed ID: 6426529 [Abstract] [Full Text] [Related]
40. Normalization of dexamethasone test associated with social support system improvement. Schwartz LS. Psychiatr J Univ Ott; 1984 Mar 23; 9(1):45-6. PubMed ID: 6374718 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]